ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 207 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $489,261 | -59.2% | 23,477 | -63.1% | 0.14% | -62.9% |
| Q1 2023 | $1,198,966 | +391.4% | 63,707 | +327.0% | 0.39% | +311.6% |
| Q3 2022 | $244,000 | +71.8% | 14,920 | +48.1% | 0.10% | +33.8% |
| Q2 2022 | $142,000 | -75.7% | 10,077 | -58.2% | 0.07% | -78.2% |
| Q1 2022 | $584,000 | +192.0% | 24,100 | +100.4% | 0.32% | +157.9% |
| Q3 2021 | $200,000 | -36.9% | 12,027 | -7.3% | 0.13% | -56.2% |
| Q2 2021 | $317,000 | -5.1% | 12,977 | +86.5% | 0.29% | -34.8% |
| Q2 2020 | $334,000 | -25.1% | 6,958 | -43.8% | 0.44% | +8.9% |
| Q3 2019 | $446,000 | +13.2% | 12,390 | -52.0% | 0.41% | +224.8% |
| Q2 2018 | $394,000 | -47.0% | 25,822 | +19.5% | 0.12% | -58.7% |
| Q1 2017 | $743,000 | +125.8% | 21,600 | +89.5% | 0.30% | +75.1% |
| Q4 2016 | $329,000 | – | 11,400 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |